Natural Products for Drug Discovery in the 21st Century: Innovations for Novel Drug Discovery
Природные продукты для открытия лекарственных средств в XXI веке: инновации для создания новых лекарственных препаратов
2018-05-25
SCID: 54.1/7b2hmuen
Discuss with AI
artificial intelligencecomputational molecular designdrug discoverynatural productsorgan-on-chip
Figures from the paper
Abstract (AI)
The therapeutic properties of plants have been recognised since time immemorial. Many pathological conditions have been treated using plant-derived medicines. These medicines are used as concoctions or concentrated plant extracts without isolation of active compounds. Modern medicine however, requires the isolation and purification of one or two active compounds. There are however a lot of global health challenges with diseases such as cancer, degenerative diseases, HIV/AIDS and diabetes, of which modern medicine is struggling to provide cures. Many times the isolation of "active compound" has made the compound ineffective. Drug discovery is a multidimensional problem requiring several parameters of both natural and synthetic compounds such as safety, pharmacokinetics and efficacy to be evaluated during drug candidate selection. The advent of latest technologies that enhance drug design hypotheses such as Artificial Intelligence, the use of 'organ-on chip' and microfluidics technologies, means that automation has become part of drug discovery. This has resulted in increased speed in drug discovery and evaluation of the safety, pharmacokinetics and efficacy of candidate compounds whilst allowing novel ways of drug design and synthesis based on natural compounds. Recent advances in analytical and computational techniques have opened new avenues to process complex natural products and to use their structures to derive new and innovative drugs. Indeed, we are in the era of computational molecular design, as applied to natural products. Predictive computational softwares have contributed to the discovery of molecular targets of natural products and their derivatives. In future the use of quantum computing, computational softwares and databases in modelling molecular interactions and predicting features and parameters needed for drug development, such as pharmacokinetic and pharmacodynamics, will result in few false positive leads in drug development. This review discusses plant-based natural product drug discovery and how innovative technologies play a role in next-generation drug discovery.
Key Findings
1
Advances in analytical and computational methods enable complex natural products to guide innovative drug design, synthesis, and molecular-target identification.
2
Artificial intelligence, organ-on-chip systems, and microfluidics are increasing the speed and automation of drug discovery and candidate evaluation.
3
Future integration of quantum computing, computational software, and databases is expected to improve prediction of molecular interactions, pharmacokinetics, and pharmacodynamics while reducing false-positive leads.
4
Modern drug discovery must evaluate natural and synthetic candidates across multiple parameters, including safety, pharmacokinetics, and efficacy, rather than activity alone.
5
Plant-derived medicines have longstanding therapeutic use, but isolating individual active compounds can sometimes eliminate the efficacy observed in complex extracts or concoctions.
Research Object
Plant-based natural products used for drug discovery
Research Subject
Their therapeutic potential and the technologies, molecular-design strategies, and drug-development parameters used to identify and evaluate novel drug candidates
Publication Details
Publication Date
2018-05-25
Journal
Publisher
ISSN
Open access PDF
Access Type
Author Information
Download PDF
Subscribe to digest